Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank21
3Y CAGR+2.3%
5Y CAGR-6.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+2.3%/yr
vs -21.4%/yr prior
5Y CAGR
-6.9%/yr
Recent acceleration
Acceleration
+23.7pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $170.01M | -32.2% |
| 2024 | $250.73M | -81.9% |
| 2023 | $1.38B | +770.1% |
| 2022 | $158.84M | +43.0% |
| 2021 | $111.09M | -54.4% |
| 2020 | $243.45M | +40.8% |
| 2019 | $172.90M | -58.4% |
| 2018 | $415.90M | +7.3% |
| 2017 | $387.56M | +23.5% |
| 2016 | $313.75M | - |